Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 18/20 | 0.58 |
| ▸ | BACE1 | P56817 | 2/20 | 0.49 |
| ▸ | CTSD | P07339 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630547 | 0.91 | ENPEP (0.55) | ENPEP | |
| SCHEMBL29888685 | 0.90 | ENPEP (0.57) | ENPEPBACE1 | |
| SCHEMBL30538341 | 0.89 | ECE1 (0.50) | ENPEPBACE1CTSD | |
| SCHEMBL30390137 | 0.89 | ENPEP (0.53) | ENPEP | |
| SCHEMBL29461510 | 0.87 | ENPEP (0.66) | ENPEP | |
| SCHEMBL29630774 | 0.87 | ECE1 (0.56) | BACE1CTSD | |
| SCHEMBL30737622 | 0.87 | ECE1 (0.56) | BACE1CTSD | |
| SCHEMBL31643257 | 0.86 | ENPEP (0.61) | ENPEPBACE1CTSD | |
| SCHEMBL32673741 | 0.86 | BACE1 (0.51) | ENPEPBACE1CTSD | |
| SCHEMBL31430933 | 0.85 | ENPEP (0.49) | ENPEPBACE1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014285-A1 | POLYPEPTIDE COMPOUND, AND COMPLEX AND USE THEREOF | Hangzhou Healthytide Biotechnology Co., Ltd. (CN) | 2026-01-15 | — | — | US | disclosed |
| EP-4556030-A1 | POLYPEPTIDE COMPOUND, AND COMPLEX AND USE THEREOF | Hangzhou Healthytide Biotechnology Co., Ltd. (CN) | 2025-05-21 | — | — | EP | disclosed |
| WO-2024012157-A1 | POLYPEPTIDE COMPOUND, AND COMPLEX AND USE THEREOF | 杭州禾泰健宇生物科技有限公司 | 2024-01-18 | — | — | WO | disclosed |
| CN-117384249-A | Polypeptide compound, complex and application thereof | 杭州禾泰健宇生物科技有限公司 | 2024-01-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014285-A1 | POLYPEPTIDE COMPOUND, AND COMPLEX AND USE THEREOF | ITGB5, ITGB3, ITGB4 | ENPEP 235/4885BACE1 1066/4885CTSD 3622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.